PineBridge Investments’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-36,808
| Closed | -$1M | – | 934 |
|
|
2019
Q4 | $1M | Sell |
36,808
-27,983
| -43% | -$762K | 0.02% | 577 |
|
|
2019
Q3 | $1.86M | Buy |
64,791
+5,563
| +9% | +$159K | 0.03% | 439 |
|
|
2019
Q2 | $1.65M | Buy |
59,228
+7,800
| +15% | +$217K | 0.03% | 428 |
|
|
2019
Q1 | $1.71M | Buy |
51,428
+33,426
| +186% | +$1.11M | 0.03% | 374 |
|
|
2018
Q4 | $524K | Buy |
18,002
+3,468
| +24% | +$101K | 0.01% | 676 |
|
|
2018
Q3 | $668K | Buy |
14,534
+2,992
| +26% | +$138K | 0.01% | 688 |
|
|
2018
Q2 | $432K | Sell |
11,542
-584
| -5% | -$21.9K | 0.01% | 719 |
|
|
2018
Q1 | $358K | Sell |
12,126
-92,157
| -88% | -$2.72M | 0.01% | 752 |
|
|
2017
Q4 | $3.58M | Buy |
104,283
+10,715
| +11% | +$368K | 0.09% | 198 |
|
|
2017
Q3 | $3.39M | Buy |
93,568
+25
| +0% | +$904 | 0.08% | 203 |
|
|
2017
Q2 | $2.42M | Buy |
93,543
+84,661
| +953% | +$2.19M | 0.06% | 239 |
|
|
2017
Q1 | $171K | Buy |
+8,882
| New | +$171K | ﹤0.01% | 829 |
|
|
2015
Q1 | – | Sell |
-3,527
| Closed | -$120K | – | 1132 |
|
|
2014
Q4 | $120K | Sell |
3,527
-7,634
| -68% | -$260K | ﹤0.01% | 876 |
|
|
2014
Q3 | $430K | Hold |
11,161
| – | – | 0.02% | 392 |
|
|
2014
Q2 | $434K | Sell |
11,161
-76,672
| -87% | -$2.98M | 0.02% | 343 |
|
|
2014
Q1 | $3M | Sell |
87,833
-3,086
| -3% | -$106K | 0.1% | 184 |
|
|
2013
Q4 | $1.91M | Buy |
90,919
+72,016
| +381% | +$1.51M | 0.06% | 254 |
|
|
2013
Q3 | $444K | Buy |
18,903
+10,192
| +117% | +$239K | 0.01% | 373 |
|
|
2013
Q2 | $234K | Buy |
+8,711
| New | +$234K | 0.01% | 456 |
|